Type of polymer/material | Incorporated/modified agents | Diameter of nanofiber (nm) | Applied cell type/animal | Main finding | Refs. |
---|---|---|---|---|---|
HMPA | –a | 10−20 | Male Sprague−Dawley rats | Increase wound recovery, formation, and blood vessel density | [91] |
HBPA | VEGF and FGF-2 | – | – | Transplant recipients achieved normoglycemia at a higher rate (78%) than control animals | [92] |
Peptide/heparin hybrid | HGF | – | Rat insulinoma β-cell line INS-1/adult male rats | HGF-loaded KLD2R/Hep gel improve β-cell survival and insulin secretion | [93] |
PCL | GO and VEGF | 10,000 | HUVECs | Increase expression of the eNOS gene in the VEGF signaling pathway | [93] |
PCL-PEG block copolymers | DNA | – | NIH3T3 cells/mice | More effective than naked DNA in terms of in vivo transfection | [94] |
PCL–PEG block copolymer | Small interfering RNA | – | Dermal fibroblasts/female C57BL/6 mice | The delivery system increased the MMP-2 gene-silencing and neo-collagen accumulation at the wound sites | [94] |
PCL–PEG diblock copolymer | hEGF | – | HDFs/female C57BL/6 mice | High hEGF expression level, significantly accelerated wound recovery rates at diabetic ulcer site | [95] |
PCL and PEG | bFGF and EGF | – | HDF cells/female C57BL/7 mice | Release system increases tissue recovery | [96] |
PCL/PEG/PCL triblock copolymer | hEGF | – | Human primary keratinocytes/female C57BL/6 mice | The NFs improved in vivo wound healing | [97] |
PLGA | Vancomycin, gentamicin, and PDGF | 371 ± 162 to 655 ± 206 | Human fibroblasts/Sprague–Dawley rats | The NFs increased amount of angiogenesis marker (CD31) and accelerated healing in the early stage | [98] |
PLAGA | FTY720 | – | C57b16/j male mice | The significantly increased the length density of vessels in the moderately diabetic mice | [25] |
PLA-PVA | CTGF | 2600 ± 1400 | 3T3 fibroblasts, HaCat keratinocytes, and EA.hy926 endothelial cells | CTGF loaded core–shell NFs improved cell viability, cell proliferation, and cell migration at ulcer site | [23] |
PELA | bFGF | 783 ± 129 | MEF/skin regeneration for diabetic rats with dorsal wounds | The release system improved collagen deposition and ECM remodeling at diabetic ulcer site | [99] |
PLGA/CNC composite | Neurotensin | 380 ± 28 | Round 0.6-cm-diameter full-thickness dermal wounds in mice | The composite NFs promote rapid healing than control groups during 2 week | [100] |
Col/HA | VEGF, PDGF, bFGF and EGF | HA: 486 + 151 Col: 534 ± 128 | HUVECs/induced diabetic rats | The delivery system accelerated wound closure rate, with elevated collagen deposition and enhanced maturation of vessels | [101] |
Eudragit RL/RS 100 | Gentamicin and rhEGF | – | Female C57BL/6 mice | The NFs mesh showed acceptable antibacterial activity and In vivo work induced faster wound healing in dorsal wounds | [102] |
PHBV/gelatin methacryloyl | EGF | 900 ± 600 to 3500 ± 1800 | 3T3 fibroblasts, HaCat keratinocytes and EA.hy926 endothelial cells | Promoting keratinocytes, fibroblasts and endothelial cells migration and proliferation and enhanced angiogenesis and in vivo wound healing | [103] |